Cargando…
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population
BACKGROUND AND AIMS: Metabolic associated fatty liver disease (MAFLD) is a serious condition, and a simple method is needed for practitioners to identify patients with the disease and have a high risk of disease progression. METHODS: We developed and validated a nomogram for fatty liver disease and...
Autores principales: | Song, Di, Ge, Qian, Chen, Ming, Bai, Song, Lai, Xiaoshu, Huang, Gege, Liu, Mengmeng, Lin, Miaofang, Xu, Jinfeng, Dong, Fajin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634768/ https://www.ncbi.nlm.nih.gov/pubmed/36381091 http://dx.doi.org/10.14218/JCTH.2021.00317 |
Ejemplares similares
-
Development and validation of a new nomogram to screen for MAFLD
por: Zou, Haoxuan, et al.
Publicado: (2022) -
MAFLD in Obese Children: A Challenging Definition
por: Di Sessa, Anna, et al.
Publicado: (2021) -
Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
por: Yang, Chenyu, et al.
Publicado: (2022) -
Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients
por: Ordoñez-Vázquez, Ana Luisa, et al.
Publicado: (2022) -
Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
por: Cordeiro, Adryana, et al.
Publicado: (2022)